A loading tool (28, 128, 228, 328, 428) for use with a drug-coated expandable medical device, the loading tool (28, 128, 228, 328, 428) comprising: a tubular sleeve having a distal end region (32, 132, 232, 333, 433), a proximal end region (30, 130, 230, 330, 430), and a lumen (33, 133, 233, 333, 433) extending therethrough; wherein the distal end region (32, 132, 232, 333, 433) includes a reduced distal tip (34, 134, 234, 334, 434) designed to interact with a hemostasis valve having a resilient seal member, the reduced distal tip (34, 134, 234, 334, 434) having a structure with a reduced dimension that allows the reduced distal tip (34, 134, 234, 334, 434) to be passed into a proximal end of the hemostasis valve in such a way to reduce displacement of the resilient seal member while the drug-coated expandable medical device is passed therethrough and that also reduces an amount of force applied by the resilient seal member onto the drug-coated expandable medical device such that a drug coating on the drug-coated expandable medical device substantially remains adhered to the drug-coated expandable medical device when passing the drug-coated expandable medical device through the reduced distal tip (34, 134, 234, 334, 434) and through the resilient seal member; wherein the lumen (33, 133, 233, 333, 433) is designed to hold the drug-coated expandable medical device while the reduced distal tip (34, 134, 234, 334, 434) is brought into contact with and passes at least partially through the resilient seal member, the lumen (33, 133, 233, 333, 433) also being a passageway for passing the drug-coated expandable medical device from a position proximal of the resilient seal member, through the resilient seal member, and into a body lumen; and wherein the proximal end region (30, 130, 230, 330, 430) includes a proximal entry port designed to allow the drug-coated expandable medical device into the lumen (33, 133, 233, 333, 433) and allow the drug-coated expandable medical device to be passed through the reduced distal tip (34, 134, 234, 334, 434), through the resilient seal member, and into the body lumen, wherein the reduced distal tip (34, 134, 234, 334, 434) comprises a plurality of axially-extending slots (36, 136) arranged about the reduced distal tip (34, 134, 234, 334, 434), wherein some of the axially-extending slots (36, 136) extend through a tube wall of the tubular sleeve, and wherein some of the axially-extending slots (36, 136) extend only partially through a tube wall of the tubular sleeve. a tubular sleeve having a distal end region (32, 132, 232, 333, 433), a proximal end region (30, 130, 230, 330, 430), and a lumen (33, 133, 233, 333, 433) extending therethrough; wherein the distal end region (32, 132, 232, 333, 433) includes a reduced distal tip (34, 134, 234, 334, 434) designed to interact with a hemostasis valve having a resilient seal member, the reduced distal tip (34, 134, 234, 334, 434) having a structure with a reduced dimension that allows the reduced distal tip (34, 134, 234, 334, 434) to be passed into a proximal end of the hemostasis valve in such a way to reduce displacement of the resilient seal member while the drug-coated expandable medical device is passed therethrough and that also reduces an amount of force applied by the resilient seal member onto the drug-coated expandable medical device such that a drug coating on the drug-coated expandable medical device substantially remains adhered to the drug-coated expandable medical device when passing the drug-coated expandable medical device through the reduced distal tip (34, 134, 234, 334, 434) and through the resilient seal member; wherein the lumen (33, 133, 233, 333, 433) is designed to hold the drug-coated expandable medical device while the reduced distal tip (34, 134, 234, 334, 434) is brought into contact with and passes at least partially through the resilient seal member, the lumen (33, 133, 233, 333, 433) also being a passageway for passing the drug-coated expandable medical device from a position proximal of the resilient seal member, through the resilient seal member, and into a body lumen; and wherein the proximal end region (30, 130, 230, 330, 430) includes a proximal entry port designed to allow the drug-coated expandable medical device into the lumen (33, 133, 233, 333, 433) and allow the drug-coated expandable medical device to be passed through the reduced distal tip (34, 134, 234, 334, 434), through the resilient seal member, and into the body lumen, wherein the reduced distal tip (34, 134, 234, 334, 434) comprises a plurality of axially-extending slots (36, 136) arranged about the reduced distal tip (34, 134, 234, 334, 434), wherein some of the axially-extending slots (36, 136) extend through a tube wall of the tubular sleeve, and wherein some of the axially-extending slots (36, 136) extend only partially through a tube wall of the tubular sleeve.